Monoclonal antibody
Type Whole antibody
Source Chimeric (primate/human)
Target CD23
Clinical data
ATC code none
CAS Number 357613-86-6 N
ChemSpider none
UNII 8Z13S29R5A YesY
KEGG D06463 YesY
 NYesY (what is this?)  (verify)

Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23).[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[1]

This drug was developed by IDEC Pharmaceuticals Corporation.


  1. 1 2 Statement On A Nonproprietary Name Adopted By The Usan Council - Gomiliximab, American Medical Association.

This article is issued from Wikipedia - version of the 10/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.